Skip to main content
. 2017 Nov;92(5):1261–1271. doi: 10.1016/j.kint.2017.04.028

Table 2.

Initial complement antigenic levels: C3, C4, CD46, and factor H (FH), factor I (CFI)

Patienta C3(0.68–1.38 g/l) C4 (0.18–0.6 g/l) CD46 FH (0.35–0.59 g/l) FI (38–58 mg/l)
2 0.57 0.15 Not tested 0.44 70
4b 0.89 0.3 Normal 0.52 41
5b 0.92 0.2 Not tested 0.29 Not tested
6b 1.08 0.36 Not tested 0.5 74
10 1.06 0.13 Not tested 0.45 68
12b 1.02 0.19 Normal 0.57 62
14 0.65 0.31 Normal 0.43 41
15 0.77 0.29 Normal 0.23 84
16 0.95 0.51 Normal 0.53 42
17 1.06 0.24 Normal 0.53 44
18 1.1 0.18 Normal 0.48 52
19b 1.23 0.52 Normal 0.48 70
20 0.51 0.16 Not tested 0.48 59
21 1.61 0.29 Normal 0.77 73
22b 1.22 0.2 Normal 0.73 78
23 0.91 0.16 Not tested 0.39 65
24 0.61 0.14 Normal 0.51 62

FH, factor H; FI, factor I.

a

Identification numbers for patients 2, 4, 5, 6, 10, and 12 correspond to those in a previous publication.9

b

Indicates patients in whom established renal failure developed.